Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Krenning

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancerCristina Müller, Roger Schibli, Eric P Krenning, et al.
Pharmaceutics|March 27, 2025
Reshaping [<sup>99m</sup>Tc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTS<sub>1</sub>R-Positive Cancer TheranosticsPanagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, et al.
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumorsDik J Kwekkeboom, Wouter W de Herder, Eric P Krenning
International Journal of Molecular Sciences|October 29, 2020
Optimizing the Profile of [<sup>99m</sup>Tc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease InhibitorsPanagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?Alida C Fröberg, Roelf Valkema, H Jaap Bonjer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)LuMark W Konijnenberg, Magda Bijster, Eric P Krenning, et al.
Nature Reviews. Endocrinology|December 11, 2013
Neuroendocrine tumours: the role of imaging for diagnosis and therapyMartijn van Essen, Anders Sundin, Eric P Krenning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 30, 2013
"To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targetingBerthold A Nock, Theodosia Maina, Eric P Krenning, et al.
Gastroenterology|July 20, 2010
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapyKjell E Oberg, Jean-Claude Reubi, Dik J Kwekkeboom, et al.
Nuclear Medicine and Biology|August 21, 2007
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneysCristina Müller, Roger Schibli, Flavio Forrer, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancerCristina Müller, Roger Schibli, Eric P Krenning, et al.
Pharmaceutics|March 27, 2025
Reshaping [<sup>99m</sup>Tc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTS<sub>1</sub>R-Positive Cancer TheranosticsPanagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, et al.
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumorsDik J Kwekkeboom, Wouter W de Herder, Eric P Krenning
International Journal of Molecular Sciences|October 29, 2020
Optimizing the Profile of [<sup>99m</sup>Tc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease InhibitorsPanagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?Alida C Fröberg, Roelf Valkema, H Jaap Bonjer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)LuMark W Konijnenberg, Magda Bijster, Eric P Krenning, et al.
Nature Reviews. Endocrinology|December 11, 2013
Neuroendocrine tumours: the role of imaging for diagnosis and therapyMartijn van Essen, Anders Sundin, Eric P Krenning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 30, 2013
"To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targetingBerthold A Nock, Theodosia Maina, Eric P Krenning, et al.
Gastroenterology|July 20, 2010
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapyKjell E Oberg, Jean-Claude Reubi, Dik J Kwekkeboom, et al.
Nuclear Medicine and Biology|August 21, 2007
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneysCristina Müller, Roger Schibli, Flavio Forrer, et al.
Pageof 18